Ayurcann Holdings Corp. (AYUR) Price & Analysis

Compare

1 Followers

AYUR Stock Chart & Stats

C$0.02

C$0.00(0.00%)

At close: Jan 02 4:00 PM EST

C$0.02

C$0.00(0.00%)

Day’s Range― - ―

52-Week RangeC$0.01 - C$0.05

Previous CloseN/A

Volume0.00

Average Volume (3M)59.98K

Market Cap

C$973.52K

Enterprise ValueC$550.67K

Total Cash (Recent Filing)C$1.09M

Total Debt (Recent Filing)C$667.58K

Price to Earnings (P/E)―

Beta0.73

Next Earnings

Mar 04, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding194,703,860

10 Day Avg. Volume17,939

30 Day Avg. Volume59,984

Financial Highlights & Ratios

PEG Ratio0.07

Price to Book (P/B)-1.65

Price to Sales (P/S)0.16

P/FCF Ratio2.14

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue GrowthTTM revenue up 55.3% demonstrates strong demand and improving market penetration for Ayurcann's products. Sustained top-line expansion can provide operating leverage, supporting margin recovery over time if management controls costs and scales manufacturing and distribution efficiently.

Proprietary Extraction TechnologyOwnership of proprietary extraction tech and product development capabilities creates durable product differentiation and quality advantages. This supports B2B sales, brand positioning and barriers to entry, enabling premium pricing and continued product innovation that can sustain margins long-term.

Diversified Revenue StreamsMultiple revenue streams — direct product sales, extract/B2B sales and partnerships/joint ventures — reduce concentration risk and broaden distribution. Structural diversification supports steadier cash flows and strategic flexibility to prioritize higher-margin channels over time.

Bears Say

Balance Sheet WeaknessNegative equity and extreme leverage signal structural solvency risk. Excessive debt restricts capital-raising options, increases financing costs, and can force dilution or asset sales, limiting the company's ability to invest in growth or withstand prolonged industry headwinds.

Weak Cash GenerationA 72.4% decline in free cash flow and negative operating cash conversion indicate poor cash generation. This increases reliance on external financing, reduces capacity to fund R&D and capital needs internally, and elevates liquidity risk during industry downturns or growth investments.

Profitability ShortfallsNegative EBIT and a -12.5% net margin show persistent unprofitability despite revenue growth. Without structural cost reduction or a shift to higher-margin products, ongoing losses will erode equity, hamper reinvestment, and challenge long-term viability even if revenue momentum continues.

Ayurcann Holdings Corp. News

Ayurcann Seeks CCAA Creditor Protection and Launches Court‑Supervised Sale Process

Ayurcann Holdings Corp. ( ($TSE:AYUR) ) has provided an announcement. Ayurcann Holdings Corp. and its subsidiary have obtained...

6d ago

Ayurcann Holdings Corp. Reports Strong Q1 2026 Sales and Market Expansion

An update from Ayurcann Holdings Corp. ( ($TSE:AYUR) ) is now available. Ayurcann Holdings Corp. reported Q1 2026...

2M ago

Ayurcann Holdings Corp. Achieves Record Revenue and Expands Market Presence

An announcement from Ayurcann Holdings Corp. ( ($TSE:AYUR) ) is now available. Ayurcann Holdings Corp. reported record gross...

3M ago

Ayurcann Holdings Corp. Reports Record Q3 2025 Growth and Expands Market Presence

An update from Ayurcann Holdings Corp. ( ($TSE:AYUR) ) is now available. Ayurcann Holdings Corp. reported record-breaking financial...

9M ago

Ayurcann Holdings Corp. Reports Record Q2 2025 Growth

An announcement from Ayurcann Holdings Corp. ( ($TSE:AYUR) ) is now available. Ayurcann Holdings Corp. has reported record-breaking...

11M ago

Ayurcann Holdings Announces Record Growth and Market Leadership

Ayurcann Holdings Corp. (TSE:AYUR) has released an update. Ayurcann Holdings Corp. has recorded a remarkable 25% revenue growth...

1y ago

Ayurcann Disputes Business Combination Termination

Ayurcann Holdings Corp. (TSE:AYUR) has released an update. Ayurcann Holdings Corp. has announced that the proposed business combination...

1y ago

Ayurcann’s Strategic Merger Bolsters Market Position

Ayurcann Holdings Corp. (TSE:AYUR) has released an update. Ayurcann Holdings Corp., a leading Canadian cannabis extraction company, is...

2y ago

Ayurcann Reports Soaring Q3 Revenue Growth

Ayurcann Holdings Corp. (TSE:AYUR) has released an update. Ayurcann Holdings Corp., a leader in Canadian cannabis extraction, has...

2y ago

Ayurcann Posts Record Revenue Growth in Q2 2024

Ayurcann Holdings Corp. (TSE:AYUR) has released an update. Ayurcann Holdings Corp. has announced a significant surge in its...

2y ago

AYUR FAQ

What was Ayurcann Holdings Corp.’s price range in the past 12 months?

Ayurcann Holdings Corp. lowest stock price was C$0.01 and its highest was C$0.04 in the past 12 months.

What is Ayurcann Holdings Corp.’s market cap?

Ayurcann Holdings Corp.’s market cap is C$973.52K.

When is Ayurcann Holdings Corp.’s upcoming earnings report date?

Ayurcann Holdings Corp.’s upcoming earnings report date is Mar 04, 2026 which is in 27 days.

How were Ayurcann Holdings Corp.’s earnings last quarter?

Currently, no data Available

Is Ayurcann Holdings Corp. overvalued?

According to Wall Street analysts Ayurcann Holdings Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Ayurcann Holdings Corp. pay dividends?

Ayurcann Holdings Corp. does not currently pay dividends.

What is Ayurcann Holdings Corp.’s EPS estimate?

Ayurcann Holdings Corp.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Ayurcann Holdings Corp. have?

Ayurcann Holdings Corp. has 194,703,860 shares outstanding.

What happened to Ayurcann Holdings Corp.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Ayurcann Holdings Corp.?

Currently, no hedge funds are holding shares in TSE:AYUR

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Ayurcann Holdings Corp.

Ayurcann Holdings Corp. (AYUR) is a Canadian company specializing in the production and distribution of cannabis-derived products, focusing on innovative formulations that cater to both the medical and recreational markets. The company operates primarily in the cannabis sector, offering a range of products including oils, capsules, and edibles, with an emphasis on quality and sustainability. Ayurcann is committed to leveraging its proprietary extraction technology and product development capabilities to meet the evolving needs of consumers in the burgeoning cannabis industry.